'Clinical trials of drugs are often done in poor countries', Supreme Court will hear the petition
Supreme Court: The Supreme Court on Wednesday said that clinical trials of drugs and vaccines are often done in poor countries. On this issue, a petitioner was allowed to file objections and present arguments against the rules made by the Center. Senior advocate Sanjay Parikh, appearing for the NGO Health Rights Forum, said that poor citizens are still being used as guinea pigs.
On Wednesday, the Supreme Court said that clinical trials of drugs and vaccines are often done in poor countries. On this issue, a petitioner was allowed to file objections and present arguments against the rules made by the Center.
A bench of Justices Rishikesh Rai and SVN Bhatti considered the arguments of Additional Solicitor General Archana Pathak Dave, appearing for the Center, who said that rules for new drugs and clinical trials were made in 2019.
Dave said that the New Drugs and Clinical Trial (Amendment) Rules were notified in 2024 to streamline the approval process for clinical trials and new drugs in India in compliance with the rules, which were aimed at improving patient safety protocols and ensuring compliance with global standards.